Literature DB >> 30336817

Intracoronary Bolus Injection Versus Intravenous Infusion of Adenosine for Assessment of Coronary Flow Velocity Reserve in Women With Signs and Symptoms of Myocardial Ischemia and No Obstructive Coronary Artery Disease.

Ahmed AlBadri, Behzad Sharif, Janet Wei, Bruce Samuels, Babak Azarbal, John W Petersen, R David Anderson, Timothy D Henry, Carl J Pepine, C Noel Bairey Merz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30336817      PMCID： PMC6655537          DOI： 10.1016/j.jcin.2018.07.052

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.075


× No keyword cloud information.
  3 in total

1.  Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

Authors:  Carl J Pepine; R David Anderson; Barry L Sharaf; Steven E Reis; Karen M Smith; Eileen M Handberg; B Delia Johnson; George Sopko; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

2.  Effects of adenosine on human coronary arterial circulation.

Authors:  R F Wilson; K Wyche; B V Christensen; S Zimmer; D D Laxson
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

3.  Intracoronary Adenosine: Dose-Response Relationship With Hyperemia.

Authors:  Julien Adjedj; Gabor G Toth; Nils P Johnson; Mariano Pellicano; Angela Ferrara; Vincent Floré; Giuseppe Di Gioia; Emanuele Barbato; Olivier Muller; Bernard De Bruyne
Journal:  JACC Cardiovasc Interv       Date:  2015-09       Impact factor: 11.195
  3 in total
  2 in total

Review 1.  Cardiovascular Imaging Techniques to Assess Microvascular Dysfunction.

Authors:  Roshin C Mathew; Jamieson M Bourque; Michael Salerno; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2019-10-11

Review 2.  The role of coronary reactivity testing in women with no obstructive coronary artery disease.

Authors:  Ahmed AlBadri; Kreton Mavromatis; C Noel Bairey Merz
Journal:  Curr Opin Cardiol       Date:  2019-11       Impact factor: 2.108
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.